Neuronetics, Inc. (STIM)

NGM – Real Time Price. Currency in USD

3.21

+0.02 (0.63%)

Market open: Aug 12, 2026, 2:50 PM EDT

3.21

+0.02 (0.63%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

11.08.2026

Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript

11.08.2026

Neuronetics Q2 Earnings Call Highlights

Neuronetics NASDAQ: STIM reported second-quarter 2026 revenue growth, a sharply narrower net loss and positive adjusted EBITDA as its Greenbrook clinic business expanded and the company introduced additional commercial purchasing options for its NeuroStar transcranial magnetic stimulation, or TMS, systems.

11.08.2026

Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates

Neuronetics (STIM) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.15 per share a year ago.

03.08.2026

Neuronetics and Jorey Chernett Announce Shared Vision

MALVERN, Pa., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics” or the “Company”) and Jorey Chernett, the Company's second largest shareholder and Managing Member of Pointillist Family Office, today announced that they have created a constructive framework for alignment between the Company's Board of Directors (the “Board”), management, and Mr. Chernett (the “Understanding”).

31.07.2026

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced the granting of inducement awards to five new non-executive employees as described below.

Videos

No Data

There is no data to display

Press releases

03.08.2026

Neuronetics and Jorey Chernett Announce Shared Vision

31.07.2026

Neuronetics, Inc. (STIM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Neuronetics, Inc. (STIM)

Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript

Neuronetics Q2 Earnings Call Highlights

Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Videos

No Data

Press releases

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript

Neuronetics Q2 Earnings Call Highlights

Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Videos

No Data

Press releases

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Search stocks

Neuronetics, Inc. (STIM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Neuronetics, Inc. (STIM)

Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript

Neuronetics Q2 Earnings Call Highlights

Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Videos

No Data

Press releases

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript

Neuronetics Q2 Earnings Call Highlights

Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Videos

No Data

Press releases

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)